Results 191 to 200 of about 27,744 (249)

Inotropes

Anaesthesia & Intensive Care Medicine, 2021
Shailendra K. Motwani, Helen Saunders
openaire   +2 more sources

The current and future status of inotropes in heart failure management

Expert Review of Cardiovascular Therapy, 2023
Introduction Heart failure (HF) is a complex syndrome with a wide range of presentations and acuity, ranging from outpatient care to inpatient management due to acute decompensated HF, cardiogenic shock or advanced HF.
A. Arfaras-Melainis, Ioannis Ventoulis, E. Polyzogopoulou, A. Boultadakis, J. Parissis   +4 more
semanticscholar   +1 more source

Does donor treatment with inotropes and/or vasopressors impact post‐transplant outcomes?

Clinical Transplantation, 2023
The purpose was to evaluate the effects of the most commonly used cardiac donor inotropes/vasopressors on subsequent post‐heart transplant survival.
D. Blitzer, D. Baran, S. Lirette, J. Copeland, H. Copeland   +4 more
semanticscholar   +1 more source

Early inotropes use is associated with higher risk of death and/or severe brain injury in extremely premature infants

Journal of Maternal-Fetal & Neonatal Medicine, 2020
Introduction: Extremely premature infants are susceptible to fluctuations in cerebral blood flow due to immaturity of cerebral autoregulation. Inotropes may cause rapid changes to systemic blood pressure and consequently cerebral blood flow, especially ...
Ahmad Nizar Abdul Aziz, Sumesh Thomas, P. Murthy, Y. Rabi, A. Soraisham, A. Stritzke, M. Kamaluddeen, E. Al-Awad, K. Mohammad   +8 more
semanticscholar   +1 more source

A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure

Journal of Cardiovascular Pharmacology, 2021
: Inotropes and inopressors are often first-line treatment in patients with cardiogenic shock. We summarize the pharmacology, indications, and contraindications of dobutamine, milrinone, dopamine, norepinephrine, epinephrine, and levosimendan.
Shuktika Nandkeolyar, Rachel Ryu, Adeba Mohammad, Kathia Cordero-Cabán, Dmitry Abramov, Huyentran N Tran, Christopher Hauschild, L. Stoletniy, Anthony Hilliard, A. Sakr   +9 more
semanticscholar   +1 more source

Increased risk of catheter‐related infection in critically ill patients given catecholamine inotropes during continuous renal replacement therapy

Hemodialysis international. International Symposium on Home Hemodialysis, 2021
Previous in vitro studies have shown that catecholamine inotropes are potent stimulators of bacterial growth and biofilm formation on catheter surfaces.
Xiaotian Liu, H. Ye, Xunhua Zheng, Zhihua Zheng, Wei Chen, Xueqing Yu   +5 more
semanticscholar   +1 more source

Positive Inotropic Agents

Annual Review of Pharmacology and Toxicology, 1984
A large number of naturally occurring and synthetically prepared chemical agents produce a positive inotropic effect on the heart. Analogues of these compounds have been isolated, prepared, and tested, and a number of them also have positive inotropic effects (see Tables 1-6).
A E, Farah, A A, Alousi, R P, Schwarz
openaire   +2 more sources

Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors

European Journal of Heart Failure
Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical evidence of tissue hypoperfusion and can lead to multi‐organ failure and death depending on its severity.
M. Riccardi, M. Pagnesi, O. Chioncel, Alexandre Mebazaa, G. Cotter, F. Gustafsson, D. Tomasoni, N. Latronico, M. Adamo, M. Metra   +9 more
semanticscholar   +1 more source